Search for a command to run...
Introduction: The angiomyolipoma of renal origin is a rare benign tumour composed of fat cells, smooth muscle cells, and thick-wall blood vessels. Mostly these are sporadic origin, asymptomatic and benign in nature. 13 Materials And Methods: cases of Renal angiomyolipoma (AML) treated in INU Bengaluru from 2015-2022 were included in the study. Demographic details, presentation, size of the lesion and treatment provided were documented. Results: All the Patients presented with either Flank pain, perirenal haematoma or frank haematuria. After initial stabilization, patients were evaluated by contrast enhanced computer tomography (CECT) & diagnosed as renal angiomyolipoma because of low Hounseld areas (10-20HU) suggestive for fat. 6 patients were managed conservatively. 3 Patients underwent angiography with selective angioembolisation. Post intervention period was uneventful. 1 patient developed perinephric abscess and PCD was placed. one patient presented with gross hematuria and underwent simple nephrectomy which also showed Leimyomatoid variant. 2 patients had association with TSC. Conclusions: Embolisation is the emergency treatment of choice for bleeding angiomyolipoma. When preventive treatment is considered a nephron sparing approach by either transarterial embolisation or partial nephrectomy is clearly important. While angiomyolipoma in both kidneys or in solitary functioning kidneys, renal preservation is mandatory in order to avoid need for renal replacement therapy. Everolimus may be considered for patients not suitable for surgery particularly in tumour seen with tuberous sclerosis.